SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005286-23-000057
Filing Date
2023-03-16
Accepted
2023-03-16 16:14:16
Documents
64
Period of Report
2022-11-27

Document Format Files

Seq Description Document Type Size
1 10-Q lndc-20221127.htm   iXBRL 10-Q 1361896
2 EX-31.1 lndc-20221127xexx311.htm EX-31.1 10249
3 EX-31.2 lndc-20221127xexx312.htm EX-31.2 10689
4 EX-32.1 lndc-20221127xexx321.htm EX-32.1 5821
5 EX-32.2 lndc-20221127xexx322.htm EX-32.2 5930
  Complete submission text file 0001005286-23-000057.txt   7174615

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20221127.xsd EX-101.SCH 40242
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lndc-20221127_cal.xml EX-101.CAL 77645
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lndc-20221127_def.xml EX-101.DEF 253712
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20221127_lab.xml EX-101.LAB 599341
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20221127_pre.xml EX-101.PRE 391206
58 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20221127_htm.xml XML 1140805
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 10-Q | Act: 34 | File No.: 000-27446 | Film No.: 23738956
SIC: 2834 Pharmaceutical Preparations